Latest / Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
CKM Systems, Triple Agonists, and a Sensor Scandal Ahead of ADA
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss several major developments in diabetes technology and obesity therapeutics, beginning with Abbott’s announcement that its dual glucose-ketone monitoring systems, Libre Duo and Libre Duo 10 Day, have received CE mark approval in Europe. The hosts describe the devices as the first continuous glucose-ketone monitors capable of simultaneously measuring glucose and ketone levels through a single wearable sensor, with real-time…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.